Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 15;14(10):3444.
doi: 10.3390/jcm14103444.

Radical Prostatectomy: Evolution of Surgical Techniques from Laparoscopy to Robotics

Affiliations

Radical Prostatectomy: Evolution of Surgical Techniques from Laparoscopy to Robotics

Tomasz Syryło et al. J Clin Med. .

Abstract

Background/Objectives: Radical prostatectomy is a standard treatment for localized prostate cancer. We aimed to compare perioperative outcomes and functional results between laparoscopic radical prostatectomy (LRP) and robot-assisted radical prostatectomy (RARP). Methods: A retrospective analysis was conducted on 120 patients who underwent LRP (n = 60) or RARP (n = 60). Perioperative parameters, including operative time, hospitalization duration, blood transfusion rate, wound healing complications, urinary catheterization duration, urinary tract infections (UTIs), and urinary incontinence, were assessed. Statistical analyses included Student's t-, Mann-Whitney U, and χ2 tests. Results: RARP was associated with significantly shorter operative time, compared with LRP (147.25 vs. 188.30 min, p < 0.0001). No significant differences were observed in hospitalization duration, transfusion rates, or overall complication rates. However, impaired wound healing was less frequent in the RARP group, with a 10% lower incidence, compared with the LRP group (p = 0.0946). Similarly, UTIs occurred less often in the RARP group (six vs. one cases; p = 0.0544). Urinary incontinence was significantly less frequent following RARP, with its incidence being more than twice as low, compared with the LRP group (p = 0.0032). Additionally, the RARP group had significantly lower International Prostate Symptom Scores, with a mean difference of 7.83 points, indicating improved urinary function. No significant differences were found in sexual function (IIEF-5 scores). Conclusions: RARP offers advantages over LRP, including reduced operative time, lower rates of wound healing complications, decreased incidence of urinary incontinence, and improved postoperative urinary function. Further studies with larger cohorts are warranted to confirm these findings and assess long-term functional and oncological outcomes.

Keywords: duration of surgery; laparoscopy; prostate cancer; robotic surgery; urinary incontinence.

PubMed Disclaimer

Conflict of interest statement

T.W.K. was supported by an American Heart Association postdoctoral fellowship AHA828786 and the National Hemophilia Foundation. The rest of the authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Graphical representation of the key findings of the study. All graphs were generated using GraphPad Prism 10 (GraphPad Software, La Jolla, CA, USA).

Similar articles

References

    1. Zhou C.K., Check D.P., Lortet-Tieulent J., Laversanne M., Jemal A., Ferlay J., Bray F., Cook M.B., Devesa S.S. Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int. J. Cancer. 2016;138:1388–1400. doi: 10.1002/ijc.29894. - DOI - PMC - PubMed
    1. Giona S. The Epidemiology of Prostate Cancer. In: Bott S.R., Lim N.K., editors. Prostate Cancer [Internet] Exon Publications; Brisbane, Australia: 2021. [(accessed on 12 May 2025)]. pp. 1–16. Available online: https://exonpublications.com/index.php/exon/article/view/358. - PubMed
    1. Culp M.B., Soerjomataram I., Efstathiou J.A., Bray F., Jemal A. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur. Urol. 2020;77:38–52. doi: 10.1016/j.eururo.2019.08.005. - DOI - PubMed
    1. Wojciechowska U., Barańska K., Miklewska M., Didkowska J.A. Cancer incidence and mortality in Poland in 2020. Nowotw. J. Oncol. 2023;73:129–145. doi: 10.5603/NJO.2023.0026. - DOI
    1. Sekhoacha M., Riet K., Motloung P., Gumenku L., Adegoke A., Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. 2022;27:5730. doi: 10.3390/molecules27175730. - DOI - PMC - PubMed

LinkOut - more resources